Edwards Lifesciences Corp (NYSE:EW)
$ 90.245 0.465 (0.52%) Market Cap: 54.38 Bil Enterprise Value: 53.10 Bil PE Ratio: 38.90 PB Ratio: 7.63 GF Score: 98/100

Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript

Sep 04, 2019 / 01:05PM GMT
Release Date Price: $73.29 (+0.58%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Edwards Lifesciences. With us, we have Mike Mussallem, Chairman and CEO; and Scott Ullem, Corporate Vice President and Chief Financial Officer; as well as Mark Wilterding, Vice President of Investor Relations. In terms of the format, it's going to be a fireside chat. If anyone has a question in the audience, please raise your hand and we will call on you. So Mike and Scott, thank you very much for being here again this year. Really appreciate it.

Michael A. Mussallem
Edwards Lifesciences Corporation - Chairman & CEO

Great.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst

So Mike, I thought we'd start kind of at a high level. It seems like Edwards is poised for strong continued growth in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot